MPWM Advisory Solutions’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$210 Hold
3
﹤0.01% 564
2026
Q1
$152 Hold
3
﹤0.01% 568
2025
Q4
$88 Hold
3
﹤0.01% 532
2025
Q3
$77 Hold
3
﹤0.01% 511
2025
Q2
$83 Hold
3
﹤0.01% 519
2025
Q1
$85 Hold
3
﹤0.01% 724
2024
Q4
$125 Buy
+3
New +$143 ﹤0.01% 724

Other funds holding MRNA

MPWM Advisory Solutions's MRNA Position: Q2 2026 in Review

MPWM Advisory Solutions held its Moderna (MRNA) position steady in Q2 2026 at 3 shares worth $210. The position accounts for ﹤0.01% of the portfolio, ranked #564.

MPWM Advisory Solutions first reported a position in MRNA in Q4 2024 and has held it in 7 quarters since. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • MPWM Advisory Solutions held 3 shares of Moderna worth $210 as of Q2 2026.
  • MPWM Advisory Solutions left its Moderna share count unchanged in Q2 2026.
  • Moderna made up ﹤0.01% of MPWM Advisory Solutions's portfolio in Q2 2026, its #564 holding.
  • MPWM Advisory Solutions first reported a position in Moderna in Q4 2024 and has held it in 7 quarters since.
  • 782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on MPWM Advisory Solutions's 13F filing for Q2 2026, filed 13 Aug 2026.